Skip to main content

Table 3 Tumor recurrence data

From: Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma

Variables

Cirrhosis

n = 68

Non- cirrhosis

n = 35

P-value

Median time to recurrence, months

13

14

0.693

Recurrence type, n (%)

 Intrahepatic recurrence

42 (61.8)

24 (68.6)

0.495

 Extrahepatic recurrence

19 (27.9)

8 (22.8)

0.578

 Both

7 (10.3)

3 (8.6)

0.780

Treatment of recurrence, n (%)

 Aggressive approach

25 (36.8)

21 (60.0)

0.025

 Rehepatectomy

3 (4.3)

5 (14.3)

0.076

 Local ablation

22 (32.4)

16 (45.7)

0.183

 Transarterial chemoembolization

26 (38.2)

9 (25.7)

0.204

 Systemic chemotherapy

5 (7.4)

2 (5.7)

0.754

 Conservative treatment

12 (17.6)

3 (8.6)

0.216